Categories AlphaGraphs, Earnings, Health Care

BIIB Earnings: Key quarterly highlights from Biogen’s Q4 2021 financial results

Biogen Inc. (NASDAQ: BIIB) reported fourth quarter 2021 earnings results today.

Total revenue decreased 4% year-over-year to $2.73 billion.

GAAP net income attributable to Biogen Inc. was $368 million, or $2.50 per share, compared to $358 million, or $2.32 per share, last year. Adjusted net income was $500 million, or $3.39 per share.

For the full year of 2022, Biogen expects revenue to range between $9.7-10 billion and adjusted EPS to range between $14.25-16.00.

Prior performance

Biogen Q3 2021 earnings

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

What awaits MongoDB (MDB) after the much-awaited turnaround?

MongoDB, Inc. (NASDAQ: MDB), the tech firm that pioneered a new method for creating databases, enables developers to work with high volumes of varied data effortlessly. The company this week

Earnings: A snapshot of GameStop’s Q3 2022 financial performance

GameStop Corp. (NYSE: GME) reported a narrower net loss for the third quarter of 2022 despite the gaming company’s sales decreasing year-over-year. The company reported a net loss of $94.7 million

Here’s why Signet Jewellers (SIG) is confident about its long-term growth opportunity

Shares of Signet Jewelers Limited (NYSE: SIG) were up 5% on Wednesday. The stock has gained 32% over the past three months. A day ago, the company delivered better-than-expected earnings

Add Comment
Viewing Highlight